HONG KONG, 8 de enero de 2025 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co., Ltd. (“Eyebright Medical”, la “Compañía”, Código de Acciones: 688050.SH, junto con sus filiales conocidas colectivamente como el “Grupo”) se enorgullece de anunciar que nuestra lente intraocular…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.